IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,656 | +236.6% | 171,950 | +272.0% | 0.02% | +300.0% |
| Q2 2023 | $492 | -90.1% | 46,229 | -90.2% | 0.00% | -90.2% |
| Q1 2023 | $4,966 | +58.9% | 472,023 | +87.1% | 0.04% | -8.9% |
| Q4 2022 | $3,125 | -99.5% | 252,217 | +339.8% | 0.04% | +462.5% |
| Q2 2022 | $661,000 | -92.8% | 57,354 | -92.2% | 0.01% | -93.2% |
| Q1 2022 | $9,231,000 | -31.2% | 733,767 | -36.2% | 0.12% | -15.8% |
| Q4 2021 | $13,418,000 | +76.8% | 1,150,745 | +98.1% | 0.14% | +36.3% |
| Q3 2021 | $7,588,000 | +50.3% | 580,985 | +48.1% | 0.10% | +82.1% |
| Q2 2021 | $5,049,000 | +144.0% | 392,341 | +112.0% | 0.06% | +86.7% |
| Q1 2021 | $2,069,000 | -50.5% | 185,096 | -49.6% | 0.03% | -26.8% |
| Q4 2020 | $4,180,000 | +49.7% | 366,972 | +18.2% | 0.04% | -26.8% |
| Q3 2020 | $2,793,000 | +1049.4% | 310,483 | +1600.5% | 0.06% | +1020.0% |
| Q4 2019 | $243,000 | +13.6% | 18,258 | -26.7% | 0.01% | -28.6% |
| Q3 2019 | $214,000 | – | 24,897 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |